Category Archives: Cancer Research

Oncotarget; Pushing towards a Disease-Free World

Many online platforms have been opened to facilitate the spread of information as the world shifts towards being digitalized. The shift which has seen people from different parts of the world change the way they do things has been taking effect slowly over the years. These changes have been felt even in the medical world where online journals like Oncotarget are being released. Oncotarget was `invented with the aim of passing important medical information to the public. This information is meant to educate the public on discoveries made about different diseases. Watch this video on Youtube.

The journal had been concentrating solely on oncology but has started focusing on other fields like cardiology, aging, pharmacology, metabolism, neuroscience, cell and molecular biology. Oncotarget has been ranked among the top most journals that are releasing information based on oncology. The reason for this high ranking is because the journal’s releases are timely, informative and can be relied on to provide factual information. They are peer-reviewed and rectified if a contradiction occurs. They are open to the public, and anyone who wishes to access them can do so freely over the internet from any corner of the world.

Due to the demand for the journals, Oncotarget now releases two or even three journals in a week. Previously, the public could only access one weekly journal, but it was judged to be necessary to increase the weekly releases since the journal was seen to be so effective in passing important info. The renowned scientist who Oncotarget works with also contributes greatly to the success of the journal. Learn more about Oncotarget at Eurekalert.org.

Many people have been benefiting significantly from the journal releases by oncotarget, and the increase of weekly releases means that the number benefiting from it will increase significantly. This means that more lives are going to be saved as people continue to be more aware of the diseases threatening their lives and how they can fight these diseases. The online coverage also makes it easier for people to access the information making it very convenient. Oncotarget should, therefore, keep up the good work and continue directing the world towards a world that is disease-free.

Read more: http://www.scimagojr.com/journalsearch.php?q=19900191708&tip=sid

Mikhail Blagosklonny Working To Increase Longevity

Readers may not know the name of scientist and researcher, Mikhail Blagosklonny, today but his work on aging may open avenues for our species to live healthier and longer than thought possible. He was educated in St. Petersburg, Russia at the First Pavlov State Medical University on Research Gate.net. Pavlov was the Russian scientist who connected stimulus and response reactions in his lab animals. Blagosklonny may someday supplant Pavlov as the most famous of Russian scientists. After graduating with an M.D. and a Ph.D., Blagosklonny became an associate professor of medicine teaching at New York Medical College, Valhalla, NY. He then took a position as a senior research scientist on linkedin.com at Ordway Research Institute in Albany, New York. In 2009 he was awarded a full professorship of Oncology at the prestigious Roswell Park Cancer Institute in Buffalo.

Mikhail Blagosklonny’s research is focused on cancer and therapies that can protect normal human cells from damage. He has a keen interest in aging and finding effective anti-aging medicines. His studies have revealed that aging is profoundly affected by the influence of genetics. His specialty is dealing with the complex study of the influence of TOR (Target of Rapamycin) effect that is being recognized as a regulator of human lifespan and affects health in various species from a simple yeast organism on through to the mammalian species.

Mikhail Blagosklonny is not only a competent professor, educator, and researcher, but has written extensively. The requirement of “publish or perish” has no effect on Blagosklonny who is prolific, writing extensively and profoundly in his field of study. His research articles are used by others in the field as a source of reference and are often cited and published in other works and journals. In this area, Jorge Hirsch developed an index that is a quick way to judge the quality of work written by other scientists. It is a metric that looks at numbers of articles written and compares it with the number of times that same article has been cited by other researchers on tandfonline.com. It simply measures quantity and quality. While a Hirsch 3 or H 3 may make universities happy with their associate professors, Blagosklonny has a Hirsch 83.

Blagosklonny continues his prolific career seeking the fountain of youth, and we can only hope that he comes from a family whose members live long productive lives. See:http://www.impactjournals.com/oncotarget/

Seattle Genetics wants to unlock cancer

Genetics plays a huge role in our lives. Genetics determines your height, hair color, eye color, and it plays a huge role in almost every other part of your life. Since Mendel, humans have tried to manipulate genetics to their own advantage. We’ve created special foods using genetics, and now medical professionals throughout the world have turned their attention toward the medical industry.

Scientists and medical professionals throughout the world strongly believe that genetics can be used to cure a variety of diseases. From the flu to cancer, genetics plays a huge role. Several companies are working on using genetics to cure several ailments. One of the leading companies in the genetics industry is Seattle Genetics.

Seattle Genetics is an extremely powerful biotechnology company. This company is focused on an antibody-based solution to cancer. They have already developed several treatments using this approach and they are showing results. Adcetris is their latest product. They produced this new drug with the help of Takeda Pharmaceutical Company. The company is having a positive impact on people with lymphoma. SGN-CD33A has also had great results. SGN-CD33A is aimed at treating acute myeloid leukemia. Seattle Genetics is extremely proud of the results they have had with their genetic therapies.

Seattle Genetics is an extremely successful biotechnology company, and they have reached this success with amazing leadership. Clay Siegall is a brilliant doctor, and he also serves as the CEO of the company. He is extremely well-respected within his field. Clay mostly works with Seattle Genetics, but he also enjoys working with several other companies. Recently, Clay was named to the board of directors at Mirna Technologies. Mirna is a great biotechnology company. They work on using microRNA to solve common health problems, and they believe that Clay’s health experience will give the company the expertise they need to grow for years to come. Clay also serves on the board of Ultragenx, and excels in his role with that company.

Seattle Genetics is an extremely influential genetics based company. They are constantly working to solve the issues that people around the world face, and they are using genetics to do it.

Learn More:

http://www.seattlegenetics.com/clay_siegall

http://seekingalpha.com/article/3969434-seattle-genetics-sgen-clay-b-siegall-q1-2016-results-earnings-call-transcript